With the spread of COVID-19, barriers to testing, treating, and getting paid for coronavirus-related care and containment efforts are being identified and addressed by federal and state regulators on a daily basis. Most recently,

  • the Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020, approving $8.3 billion in federal funds to address the conoravirus emergency, signed into law on March 6, included provisions easing restrictions on physicians and licensed health care practitioners treating existing patients through telehealth services;
  • the State of California declared coronavirus testing a preventive health service, prohibiting copayments from plan members and insureds for diagnostic tests; and
  • the Centers for Medicare and Medicaid announced that it was diverting all survey and accreditation services to institutional infection control surveys, requiring hospitals and health care facilities to review and implement infection control processes and issued additional memoranda on reimbursement issues.

The firm’s Health Care Group is monitoring these developments and advising clients across the industry on regulatory and transactional matters, including health benefits.


Copyright © 2020 by Ballard Spahr LLP.
www.ballardspahr.com
(No claim to original U.S. government material.)

All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, including electronic, mechanical, photocopying, recording, or otherwise, without prior written permission of the author and publisher.

This alert is a periodic publication of Ballard Spahr LLP and is intended to notify recipients of new developments in the law. It should not be construed as legal advice or legal opinion on any specific facts or circumstances. The contents are intended for general informational purposes only, and you are urged to consult your own attorney concerning your situation and specific legal questions you have.